|
GB732581A
(en)
|
1952-01-18 |
1955-06-29 |
Ciba Ltd |
Manufacture of hydrazine compounds
|
|
DE1006423B
(de)
|
1952-01-18 |
1957-04-18 |
Ciba Geigy |
Verfahren zur Herstellung von Hydrazinophthalazinen
|
|
US3274194A
(en)
*
|
1963-03-29 |
1966-09-20 |
Miles Lab |
Quinazolinedione derivatives
|
|
GB1062357A
(en)
|
1965-03-23 |
1967-03-22 |
Pfizer & Co C |
Quinazolone derivatives
|
|
GB1293565A
(en)
*
|
1969-05-03 |
1972-10-18 |
Aspro Nicholas Ltd |
Aminophthalazines and pharmaceutical compositions thereof
|
|
US3919425A
(en)
*
|
1971-04-09 |
1975-11-11 |
Miles Lab |
Method of producing vasodilation using certain 3-substituted-quinazoline derivatives
|
|
BE792206A
(cg-RX-API-DMAC7.html)
|
1971-12-02 |
1973-06-01 |
Byk Gulden Lomberg Chem Fab |
|
|
FR2436781A1
(fr)
|
1978-09-19 |
1980-04-18 |
Berri Balzac |
Derives d'amino-3 (1h,3h) quinazolinedione-2,4, leur procede de preparation et leurs applications en therapeutique
|
|
US4335127A
(en)
*
|
1979-01-08 |
1982-06-15 |
Janssen Pharmaceutica, N.V. |
Piperidinylalkyl quinazoline compounds, composition and method of use
|
|
JPS5976082A
(ja)
|
1982-10-23 |
1984-04-28 |
Kyowa Hakko Kogyo Co Ltd |
新規なピペリジン誘導体
|
|
JPS60120872A
(ja)
|
1983-12-01 |
1985-06-28 |
Kyowa Hakko Kogyo Co Ltd |
新規なヘテロ環状化合物及び強心剤
|
|
US5001125A
(en)
|
1984-03-26 |
1991-03-19 |
Janssen Pharmaceutica N.V. |
Anti-virally active pyridazinamines
|
|
MA20387A1
(fr)
|
1984-03-26 |
1985-10-01 |
Janssen Pharmaceutica Nv |
Pyridazinamines utiles comme agents anti-viraux et procede pour leur preparation
|
|
DK623586A
(da)
|
1985-12-27 |
1987-06-28 |
Eisai Co Ltd |
Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
|
|
US5231184A
(en)
*
|
1987-11-23 |
1993-07-27 |
Janssen Pharmaceutica N.V. |
Pridazinamine derivatives
|
|
US5177075A
(en)
*
|
1988-08-19 |
1993-01-05 |
Warner-Lambert Company |
Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
|
|
CA2002864C
(en)
|
1988-11-29 |
1999-11-16 |
Eddy J. E. Freyne |
(1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
|
|
GB8827822D0
(en)
*
|
1988-11-29 |
1988-12-29 |
Janssen Pharmaceutica Nv |
(1h-azol-1-ylmethyl)substituted quinoline derivatives
|
|
US5374637A
(en)
*
|
1989-03-22 |
1994-12-20 |
Janssen Pharmaceutica N.V. |
N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
|
|
EP0391462A1
(en)
|
1989-04-05 |
1990-10-10 |
Janssen Pharmaceutica N.V. |
Synergistic compositions containing ketanserin
|
|
US5160727A
(en)
|
1990-02-13 |
1992-11-03 |
Warner-Lambert Company |
Tumor cell sensitization method using quinazolinedione derivatives
|
|
IE913473A1
(en)
*
|
1990-10-15 |
1992-04-22 |
Fujisawa Pharmaceutical Co |
Quinazoline derivatives and their preparation
|
|
JP3333878B2
(ja)
|
1992-04-23 |
2002-10-15 |
メレルダウファーマスーティカルズ インコーポレイテッド |
セロトニン5ht2拮抗剤としての4‐イミドメチル‐1‐[2’フェニル‐2’オキソエチル‐]ピペリジン類,それらの製法及び治療用途
|
|
TW294595B
(cg-RX-API-DMAC7.html)
|
1992-11-20 |
1997-01-01 |
Janssen Pharmaceutica Nv |
|
|
CA2118117A1
(en)
|
1993-02-18 |
1994-08-19 |
Shigeki Fujiwara |
Adenosine uptake inhibitor
|
|
GB9404485D0
(en)
|
1994-03-09 |
1994-04-20 |
Cancer Res Campaign Tech |
Benzamide analogues
|
|
TW445263B
(en)
|
1996-02-29 |
2001-07-11 |
Janssen Pharmaceutica Nv |
Novel esters of 1,4-disubstituted piperidine derivatives
|
|
JPH107572A
(ja)
|
1996-06-17 |
1998-01-13 |
Sumitomo Pharmaceut Co Ltd |
腫瘍壊死因子産生阻害剤
|
|
DE59711622D1
(de)
|
1996-09-10 |
2004-06-17 |
Boehringer Ingelheim Pharma |
Abgewandelte aminosäuren, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
EP0999208A4
(en)
*
|
1997-05-30 |
2001-08-08 |
Meiji Seika Kaisha |
NITROGEN-BASED HETEROCYCLIC COMPOUNDS AND MEDICINES FOR TREATING HYPERLIPEMIA THAT CONTAIN THEM
|
|
JPH10330377A
(ja)
|
1997-06-02 |
1998-12-15 |
Kyowa Hakko Kogyo Co Ltd |
ピペリジン誘導体
|
|
US6635642B1
(en)
*
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
|
US20020022636A1
(en)
*
|
1997-09-03 |
2002-02-21 |
Jia-He Li |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
|
US6407116B1
(en)
|
1997-09-16 |
2002-06-18 |
Takeda Chemical Industries, Inc. |
Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
|
|
US6133277A
(en)
|
1997-12-05 |
2000-10-17 |
Janssen Pharmaceutica N.V. |
(Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
|
|
JP2000191659A
(ja)
|
1999-01-04 |
2000-07-11 |
Sumitomo Pharmaceut Co Ltd |
腫瘍壊死因子産生阻害剤
|
|
EP1147112B1
(en)
|
1999-01-29 |
2003-10-29 |
Abbott Laboratories |
Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
|
|
US7265115B2
(en)
*
|
1999-01-29 |
2007-09-04 |
Abbott Laboratories |
Diazabicyclic CNS active agents
|
|
US6566372B1
(en)
*
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
|
CN1703403A
(zh)
*
|
2000-10-02 |
2005-11-30 |
詹森药业有限公司 |
趋代谢的谷氨酸盐受体拮抗剂
|
|
ITMI20002358A1
(it)
|
2000-10-31 |
2002-05-01 |
Flavio Moroni |
Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
JP2002284699A
(ja)
|
2001-03-28 |
2002-10-03 |
Sumitomo Pharmaceut Co Ltd |
視細胞変性疾患治療剤
|
|
US20040176361A1
(en)
*
|
2001-05-23 |
2004-09-09 |
Masakazu Fujio |
Fused heterocyclic compound and medicinal use thereof
|
|
KR100957516B1
(ko)
|
2001-08-15 |
2010-05-14 |
이코스 코포레이션 |
2h-프탈라진-1-온 및 이것의 사용 방법
|
|
CA2465491A1
(en)
|
2001-11-07 |
2003-05-15 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
AUPR975601A0
(en)
|
2001-12-24 |
2002-01-31 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivatives
|
|
US6822097B1
(en)
*
|
2002-02-07 |
2004-11-23 |
Amgen, Inc. |
Compounds and methods of uses
|
|
AUPS137402A0
(en)
*
|
2002-03-26 |
2002-05-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel tricyclic compounds
|
|
NZ535438A
(en)
|
2002-03-29 |
2006-08-31 |
Janssen Pharmaceutica Nv |
Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
|
|
US7119111B2
(en)
|
2002-05-29 |
2006-10-10 |
Amgen, Inc. |
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
|
|
ATE540928T1
(de)
*
|
2002-11-22 |
2012-01-15 |
Mitsubishi Tanabe Pharma Corp |
Isochinolinverbindungen und ihre medizinische verwendung
|
|
US20050075364A1
(en)
|
2003-07-01 |
2005-04-07 |
Kap-Sun Yeung |
Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
|
|
NZ546991A
(en)
|
2003-11-20 |
2010-01-29 |
Janssen Pharmaceutica Nv |
6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as PARP inhibitors
|
|
NZ546990A
(en)
*
|
2003-11-20 |
2010-03-26 |
Janssen Pharmaceutica Nv |
7-Phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
|
PT1689715E
(pt)
|
2003-12-03 |
2011-05-16 |
Ym Biosciences Australia Pty |
Inibidores da tubulina
|
|
JP4806353B2
(ja)
*
|
2003-12-05 |
2011-11-02 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ポリ(adp−リボース)ポリメラーゼインヒビターとしての6−置換2−キノリノンおよび2−キノキサリノン
|
|
ES2565581T3
(es)
|
2003-12-10 |
2016-04-05 |
Janssen Pharmaceutica Nv |
2-Quinolinonas/2-quinoxalinonas 6-(hetero)ciclohexilalquil sustituidas como inhibidores de poli(ADP-ribosa) polimerasa
|
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
WO2005117876A1
(en)
|
2004-06-01 |
2005-12-15 |
University Of Virginia Patent Foundation |
Dual small molecule inhibitors of cancer and angiogenesis
|
|
WO2006003147A1
(en)
|
2004-06-30 |
2006-01-12 |
Janssen Pharmaceutica N.V. |
Phthalazine derivatives as parp inhibitors
|
|
CA2568835C
(en)
|
2004-06-30 |
2014-05-27 |
Janssen Pharmaceutica N.V. |
Quinazolinone derivatives as parp inhibitors
|
|
JP5100376B2
(ja)
*
|
2004-06-30 |
2012-12-19 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Parp阻害剤としてのキナゾリンジオン誘導体
|
|
NZ560712A
(en)
|
2005-02-17 |
2010-12-24 |
Synta Pharmaceuticals Corp |
(3,4,5-trisubstituted-phenyl)isoxazole combretastin derivatives for the treatment of disorders
|
|
CN101166732B
(zh)
*
|
2005-04-28 |
2013-04-17 |
田边三菱制药株式会社 |
氰基吡啶衍生物及其作为药物的应用
|
|
CN101316592A
(zh)
|
2005-08-24 |
2008-12-03 |
伊诺泰克制药公司 |
茚并异喹啉酮类似物及其用法
|
|
CA2640678C
(en)
|
2006-02-03 |
2015-03-31 |
Bionomics Limited |
Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
|
|
EP2468748B1
(en)
|
2006-02-15 |
2016-05-25 |
AbbVie Inc. |
Pyrazoloquinolones are potent parp inhibitors
|
|
US8466150B2
(en)
*
|
2006-12-28 |
2013-06-18 |
Abbott Laboratories |
Inhibitors of poly(ADP-ribose)polymerase
|
|
JP5545955B2
(ja)
|
2007-03-08 |
2014-07-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Parpおよびtank阻害剤としてのキノリノン誘導体
|
|
US8153633B2
(en)
*
|
2007-06-25 |
2012-04-10 |
Amgen Inc. |
Phthalazine compounds, compositions and methods of use
|